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Catalase Activity Mediates the Inhibitory Actions of 24,25 Dihydroxyvitamin 0 3 
by 
Sven L. Peery , Master of Science 
Utah State University, 2006 
Major Professor: Dr. Ilka Nemere 
Department: Nutrition and Food Sciences 
The steroid hormone 1,25-dihydroxyvitamin 0 3 [1,25(0H) 20 3] rapidly stimulates 
the uptake of phosphate in isolated chick intestinal cells , while the steroid 24 ,25-
dihydroxyvitamin 0 3 [24,25(0H) 20 3] inhibits the rapid stimulation by l ,25(0H)20 3. 
Earlier work in this laboratory has indicated that a cellular binding protein for the 
24,25(0H) 20 3 is the enzyme catalase. Since binding resulted in decreased catalase 
activity and increased H20 2 production , studies were undertaken to determine if pro-
oxidant conditions mimicked the inhibitory actions of 24,25(0H) 20 3, and anti-oxidant 
conditions prevented the inhibitory actions of 24,25(0H)2D3. An antibody against a 
putative 24,25(0H) 20 3 binding protein was found to neutralize the inhibitory effect of the 
steroid on 1,25(0H) 20 3-mediated 
32P uptake (P<0.05 to 0.001 at T=3-10 min of 
incubation). Incubation of cells in the presence of 50 nM catalase was also found to 
alleviate inhibition at T=5-10 min of incubation . In another series of experiments, 
isolated intestinal epithelial cells were incubated as controls or with 1,25(0H) 20 3, each in 
lV 
Cells exposed to hormone alone again showed an increased accumulation of 
32
P from 
T=5-10 min, while cells treated with catalase inhibitor and hormone had uptake levels 
that were indistinguishable from controls. We tested whether inactivation of protein 
kinase C (PKC), the signaling pathway for 32P uptake, occurred. Incubation of cells with 
100 nM phorbol-13-myristate (PMA) increased 32P uptake to 143% of controls, while 
cells pretreated with 50 µM H20 2 prior to PMA did not exhibit increased uptake . 
Likew ise, PMA significantly increased PKC activity at T= 1-3 min (P< 0.05, relative to 
corresponding controls), while cells exposed to H20 2 prior to PMA did not. It is 
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When vitamin D was discovered in 1922 it was considered a nutritional factor. It 
has since been categorized as a pre-honnone rather than a vitamin. A major reason for 
this belief is that most of the vitamin D utilized by higher animals is manufactured in the 
skin by a photochemical process . Under these conditions , vitamin Dis not required in the 
diet, so it does not meet the definition of a vitamin. Moreover, it is further metabolized 
into more active forms, which is a property of a pre-hormone. Vitamin D is the name 
applied to two fat-soluble substances that are also known as cholecalciferol (in animals) 
and ergocalciferol (in plants and yeasts) in its inactive state. For activation , 
cholecalciferol must first be converted into 25(0H)D 3 in the liver where it is 
hydroxy lated at carbon-25 (see appendix A for a complete list of abbreviations .). In the 
kidney, 25(0H)D 3 is either hydroxylated at carbon-I or carbon-24 . 1,25(0H) 2D3 is a 
hormonally active secosteroid (a compound in which the Bring has been cleaved). 
24,25(0H)2D3 is another metabolite which was thought to be hormonally inactive, but is 
beginning to be appreciated as a hormone as well [Henry and Norman, 1978; Ono et al., 
1996; Somjen et al., 1983]. 
The liver appears to be the major site of 25-hydroxylation in mammals. In the 
chicken however , the 25-hydroxylase enzymes exist in extra-hepatic sites such as the 
kidney and the intestines. It is generally thought by many that although this steroid 
(25(0H)D 3) is a major circulating metabolite of cholecalciferol it must undergo chemical 
modification to 1,25(0H)2D 3 or 24,25(0H) 2D3 before it can function as a hormone. 
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However, reports by Olson and DeLuca [1969] and Phadnis and Nemere [2003] suggest 
that 25(0H) 2D3 may have activity in promoting calcium transport (see below). 
A well-studied vitamin D metabolite target organ is the intestine. In the intestine, 
the nuclear receptor for the metabolite, l,25(0H)zD 3 may regulate the biosynthesis of 
vitamin D dependent calcium binding protein (CaBP) , termed calbindin-D 28k which binds 
Ca2+ with high affinity [Minghetti et al., 1988; Corradino et al., 1968; Corradino and 
Wasserman , 1968]. However , it may be that the increase in calcium absorption stimulates 
the CaBP synthesis, since Spencer et al. [ 1976] found that enhanced transport preceded 
the appearance of CaBP. 
Mechanisms of Biological Action 
o.f Vitamin D Metabolit es 
Thus far, the three known active metabolites of Vitamin Dare 25(0H)D 3; 
1,25(0H) 2D3; 24,25(0H) 2D3 (see table 1 below for summary of metabolites) . While 
25(0H)D 3 causes an increase in calcium uptake in rat duodena [Olson and DeLuca 1969], 
it has also been shown to increase calcium transport in the perfused duodenal loops of 
chicks . In isolated chick enterocytes and perfused duodenal loops , Zhao and Nemere 
[2002] reported that 1,25(0H)2D 3 increases phosphate uptake and transport . On the other 
hand , 24,25(0H) 2D3 has an inhibitory effect when administered in the presence of 
1,25(0H) 2D3 [Nemere l 996a; Nemere et al., 2002; Zhao and Nemere, 2002]. The most 
commonly studied metabolite of vitamin Dis l ,25(0H) 2D3. It has been shown that this 
metabolite acts both by genomic and membrane-initiated actions [Nern ere, 1996b]. 
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Table 1. Vitamin D metabolite action summary 
Metabolite Sight of Proposed Reference 
activation Action 
25(0H)D3 Liver i CAL+ Olson EB, DeLuca HF 25-
uptake in rat hydroxycholecalciferol: direct effect on 
& chick calcium transport. 
duodena Science. 1969 Jul 25;165(891):405-7. 
I ,25(0H)2D3 Kidney i phosphate Zhao B. and Nemere I. l ,25(0H) 2D3-
uptake and mediated phosphate uptake in isolated 
transport in chick intestinal cells: effect of 
intestine 24 ,25(0H)2D 3, signal transduction 
activators, and age . J. Cell Biochem. 
2002;86(3 ):497-508 
24,25(0H) Kidney l phosphate Nemere , I. l 996a. Apparent non-nuclear 
2D3 uptake in the regulation of intestinal phosphate transport: 
presence of effects of 1,25-dihydroxyvitamin D3, 
1,25(0H) 2D3 24,25 -dihydroxyvitamin 0 3, an.d 25-
in intestine hydroxyvitamin D3.Endocrinology. 1996 
Jun; 137(6):2254-61. 
Various genomic (nuclear) actions of vitamin D have been found to promote 
synthesis of calcium transport pathway elements such as ion carriers. Early evidence for 
lysosomes as vesicular carriers came from electron microscopic studies. Jande and 
Brewer [1974) observed that vitamin D repletion of vitamin D deficient chicks resulted in 
the proliferation of intestinal epithelial cell lysosomes. Warner and Coleman [ 1975) used 
X-ray probe analysis in conjunction with electron microscopy , and found that during 
transport , calcium was found in discrete localizations suggesting a vesicular 
accumulation, as opposed to a diffuse cytoplasmic route. 
Nemere et al. [1986) using biochemical techniques to study subcellular organelles 
reported that regardless of the vitamin D status, the highest levels of 45Ca were found in 
lysoso mal fractions during transport. Lysosornal fractions were also the only subcellular 
4 
compartment to exhibit a 1,25(0H)2D 3-induced increase in 
45 Ca content. Time course 
[Nemere and Nonnan, 1988] and dose response studies [Nemere, 1999] further supported 
the vesicular carrier hypothesis. 
In two separate studies Nemere et al. [1986c , 1991] reported that lysosomes were 
found to be emiched in calbindin-D 28k. Using ELISA in combination with subcellular 
fractionation studies, lysosomal fractions were found to be enriched in calbindin-D 28k 
although most of the protein remained soluble. It was recognized that soluble CaBP could 
be due to a homogenization effect. Using electron microscopyNemere et al. [1991] found 
very little cytoplasmic calbindin D28k while most of the immuno-reactive protein was in 
smali transpo1i vesicles and iysosomes . 
Microtubules are also deemed to be a potential regulatory point for the genomic 
actions of vitamin D. An estimation of the a-tubulin mRNA by dot blot analysis [Nemere 
et al., 1987] revealed that in chick intestine after 1,25(0H)2D 3 treatment there were 
decreasing levels of messa ge but increasing levels of protein. The inverse relation 
between a-tubulin and its message has been ascribed to auto regulation [Cleveland and 
Sullivan, 1985]. 
Membrane Initiat ed Actions 
It can be argued that when an animal reaches a Ca2+ deficient state, it would be 
beneficial to obtain crucial Ca2+ rapidly from the diet without delay due to gene 
transcription in the nucleus. Given the pivotal role of Ca2+ in muscle contraction , nerve 
impulse conduction, and other physiologic phenomena, such a rapid respo nse could be 
life saving for the organism . 
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The first evidence for rapid effects was obtained 30 years ago [Toffolon et al., 
1975]. Toffolon et al. [1975] reported that within 30 min of 1,25(0H)2D 3 administration 
in vivo, subsequently prepared everted gut sacs from rats responded with enhanced 
calcium transport, relative to control preparations. The authors speculated that the 
secosteroid hormone might become inserted into the lipid bilayer of the apical membrane 
of the intestinal cells and thereby exert a direct membrane effect. 
A direct rapid effect of 1,25(0H) 2D3 on calcium uptake was first observed in 
isolated intestinal epithelial cells from the rat, where the authors postulated that a 
membrane-locali zed receptor might be responsible for initiating the effects observed 
[Nemere and Szego , l 98i a,b]. Using rat enterocytes Lieberherr et al. [ 1989] reached a 
similar conclusion regarding the need for a cell surface receptor to mediate 
developmental changes in 1,25(0H)2D 3 stimulated phosphoinositide metabolism 
(apparent within 5 sec of honnone treatment). Further downstream of the initial 
phosphoinositide turnover stimulated by 1,25(0H) 2D3, protein kinase C (PKC) has also 
been found to be involved in mediating rapid responses in the rat colonic epithelium and 
Caco- 2 cells [Wah et al., 1990, 1992; Khare et al., 1994]. 
A similar phenomenon has been found in fresh water fish that live in a relatively 
low Ca2+ enviromnent : 1,25(0H) 2D3 induces rapid Ca
2
+ transport in perfused intestinal 
preparations while no such effect is observed in marine fish that live in a high Ca2+ 
environment [Sundell and Bjomsson , 1990]. Physiologically relevant concentrations of 
24,25(0H) 20 3 however, decreased Ca
2
+ transport in the perfused intestine of the Atlantic 
cod , a marine fish [Sundell and Bjomsson, 1990; Larsson et al., 1995]. 
The perfused chick duodenal loop is a valuable system for the study of rapid 
actions of l ,25(0H)2D 3 and 24,25(0H) 2D3, including modulation of intestinal Ca
2
+ and 
phosphate transport [Nemere et al., 1984, 1986, 1996a]. In this system it was observed 
that 1,25(0H) 2D3 acts at the basal lateral membrane (BLM) surface and not at the brush 
border [Nemere et al., 1984; Nemere 1996a,b]. This observation suggests binding to a 
membrane receptor, rather than non-specific membrane insertion by 1,25(0H)2D3 as the 
initiating effect. The biphasic dose response curve for both steroid mediated Ca2+ and 
phosphate transport is also characteristic of membrane receptors. 
Evidence for the Biological Effect 
of24,25(0HJ 2D3 
The metabolite 24,25(0H) 2D3 is preferentially produced when an animal is 
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calcium- , phosphate- , and 1,25(0H) 2D3 replete . Thus, it may be an endogenous inhibitor 
of 1,25(01-J.)20 3. In this regard , it has been shown that 24,25(0H) 2D3 suppresses the 
rapid actions of l ,25(0H) 2D3 on phosphate and calcium transport in the chick intestine 
[Nemere , 1996a, 1999]. At a cellular level 24,25(0H) 2D3 has been found to inhibit the 
rapid membrane initiated effects of 1,25(0H) 2D3 on opening of calcium channels in 
osteoblasts and osteosarcoma cells [Yukihiro et al., 1994; Khoury et al., 1995; Takeuchi 
and Guggino , 1996] and PKC activation in chick enterocytes [Nemere, 1999]. 
Proposed Mechanism of24,25(0H)2D3 
Action 
Growing evidence has shown that 24,25(0H)2D 3 has specific, physiologically 
significant actions that are distinct from l ,25(0H) 2D3. Larsson et al. [2006] recently 
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identified catalase as an endogenous 24,25(0H)2D 3 binding protein. It should be noted 
that catalase has been found tight! y bound to the cell surface in other tissues [Watanabe et 
al., 2003]. This finding suggests a mechanism for signal transduction, acting as a 
membrane recognition moiety that subsequently directs the steroid to intracellular 
organelles. The peroxisomal marker enzyme catalase, is well known for its ability to 
eliminate hydrogen peroxide. Hydrogen peroxide in tum, has recently been implicated as 
a newly found signal transducer [Wantanabe et al., 2003; Waypa et al., 2002; Wood et 
al., 2003; Yano and Yano, 2002]. Nemere et al. [manuscript submitt ed] went on to 
investigate the potential role of reactive oxygen species in 24,25(0H) 2D3 signaling. This 
study found that the fonctiona! consequence of 24,25(0H)2D 3 binding was to decrease 
catalase activity, with an ensuing increase in hydrogen peroxide production, which in turn 
inhibited 1,25(0H) 2D3-stimulated phosphorus uptake. These findings suggested that a 
target of inhibitor y oxidation might be the 1,250 3-MARRS protein , which contains two 
thioredoxin folds [Nemere et al., 2004]. The reduced thiols are most likely responsible for 
protein-protein interactions that allow for positi ve ly cooperative binding [Larsson and 
Nemere, 2003] , and may facilitate movement of the 1,250 3-MARRS protein to the 
nucl eus following ligand bindin g [Nemere et al., 2000; Rohe et al., 2005]. Incubation of 
enterocytes with either 24,25(0H) 2D3 or hydrogen peroxide for greater than 5 minutes, 
reduced binding of 1,25(0H) 2D3 by the 1,250 3-MARRS receptor. Binding could 
however be restor ed in the presence of dithiothreitol indicating the invol vement of thiol 
groups. Bindin g by the VDR in the same cells was not decreased by 24,25(0H)2D 3 but 
ach1ally increa sed after addition of hydrogen pero xide. The authors concluded with 
evidence that enhanced binding by the VDR after exposure to reactive oxygen species 
suggested the existence of a mechanism to preserve transcriptional effects mediated by 
the VDR [Nemere et al., 2006 manuscript submitted). 
Thesis Proposal 
With mounting evidence suggesting nongenomic actions of 24,25(0H)zD 3, I 
tested the hypothesis that pro-oxidant states inhibit 1,25(0H) 2D3 action on uptake of 
phosphorus, and that anti-oxidant conditions promote 1,25(0H)zD 3-mediated uptake of 
phosphorus. The specific aims were as follows: 
1. To detennine the effect of Ab 365 (against the 24,25(0H) 2D3 binding protein) on 
32P 
uptake in intestinal cell suspensions. This represented an anti-oxidant condition. 
2. To determine the effect of exogenous catalase on 32P uptake of cells treated with 
honnone . This represented an additional anti-oxidant condition: 
3. To determine the effect of a catalase inhibitor on 32P uptake in intestinal cell 
suspensions (A pro-oxidant condition) . 
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4. To determine whether pro-oxidant conditions inhibited PKC signaling directly, rather 
than by way of inhibiting ligand binding to the 1,250 3-MARRS receptor. Phorbol ester (a 
direct activator of PKC) stimulates phosphate uptake without prior activations of the 
1,250 3-MARRS receptor. 
A schematic diagram of the functional cellular relationship between the 1,250 3-MARRS 
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Fig. 1. Model of endocrine feedback of 24 ,25(0H) 2D3 on the rapid actions of 
l ,25(0H) 2D3. l ,25(0H) 2D3 binds to the l ,25D 3-MARRS receptor in the basal lateral 
membrane. The two thioredoxin homology domains provide a means for protein-protein 
interactions, including positive coopertivity in ligand binding [Larsen & Nemere 
2003a,b]. Binding of l ,25(0H) 2D3 stimulates at least two signal transduction pathways. 
Increased PKA activity stimulates Ca uptake and transport, [Nemere 2002; Phadnis & 
Nemere 2003] whi le increased PKC activity stimul ates Pi uptake and transport [Zhao & 
Nemere; Nemere et al 2004]. The metabolite 24,25(0H) 2D3 is known to inhibit 
1,25(0H) 2D3 stimulated uptake and transport of these ions [Nemer e 1999]. By binding to 
catalase, 24,25(0H) 2D3 decreases enzyme activity and increases H20 2 production 
[Nemere et al. manuscript submitted] , thereby oxidizing sulfhydryls in the l ,25D 3-
MARRS receptor to inhibit 1,25(0H) 2D3 binding. In addition, PKC signa l transduction is 
also directly in11ibited. 
CHAPTER II 
MATERIALS AND METHODS 
Animals and Surgical Procedures 
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All procedures were approved by Utah State University Institutional Animal Use 
and Care Committee . White leghorn cockerels were obtained on the day of hatch (Privett 
Hatchery , Portales , NM) and raised on a vitamin D-replete diet (Nutrena Feeds, Murray, 
UT) generally for 3-7 weeks prior to experimentation. On the day of use , chicks were 
anesthetized with 0.3 ml chloropent/lOOg of body weight. The abdominal cavity was 
surgically opened and the duodenal loop was removed. The duodenal loop was chilled in 
ice-cold saline (0 .9% NaCl) for 15 min , the pancreas excised, and the loop everted. The 
duodenal loop was then rinsed with chilled saline . 
Isolation ofEpithelial Cells 
Intestinal epithelial cells were isolated by the citrate chelation method (Nemere 
and Campbell, 2000). The duodenal loop was transferred to 30 ml of Solution A [medium 
first described by Weiser [1973], containing 96 mM NaCl, 1.5 mM KCl , 8 mM KH2P04 
5.6 mM Na 2HP0 4 27 mM sodium citrate, pH 5.0 [Nemere et al. , 2004; Sterling and 
Nemere, 2005] and stitTed for 15 min to release the cells. The intestinal segment was then 
transfeITed to fresh buffer and the process was repeated twice with 30 ml aliquots of 
Solution A. The cells were collected from the pooled isolation media by centrifugation at 
500 x g for 5 min at 4° C. After decanting the supernatant , and while still in the inverted 
position , the inside of the tube was swabbed with a Kim wipe. The intestinal cells were 
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resuspended in 20 ml of Gey's Balanced Salt Solution (GBSS) lacking bicarbonate 
[Sterling and Nemere, 2005] and containing 119 mM NaCl, 4.96 mM KC!, 0.22 mM 
KH2P0 4, 1.03 mM MgC12.6H20 , 0.28 mM MgS0 4, 0.9 mM CaCh pH 7.0, by gentle 
dispersion with a Teflon-coated rod to avoid breaking the fragile intestinal cells, followed 
by drop wise addition of GBSS. 
32P Uptake and Ab 365 to the 24,25(0H)2D3 
Binding Prot ein 
Fourteen milliliters of the cell suspension in GBSS was removed to a 
polypropylene tube (Falcon, Fischer Scientific) containing 28 µCi of H/ 2P0 4 (Perkin 
Elmer Life Sciences, Boston MA) , thereby initiating the time course . Aliquots (3.2 ml) of 
cell suspension were then pipetted into four fresh polypropylene tubes, three of which 
contained Ab 3 65 (11100 dilution , final concentration) against the 24,25(0H)2D3 binding 
protein. One hundred-rnicroliter aliquots were remo ved at T = -5 min and -1 min to 
establish basal uptake rates of 32P. At T =O min, the cells were treated with the vehicle 
ethanol(< 0.05% final concentration) or steroids to give the following incubation 
conditions: (1) controls plus Ab 365; (2) 300 pM l ,25(0H)2D3 plus Ab 365 ; (3) 300 pM 
l ,25(0H) 2D3 plus 6.5 nM 24,25(0H) 2D3 ;or (4) 300 pM l ,25(0H) 2D3 plus 6.5 nM 
24,25(0H) 2D3 plus antibody (Ab) 365. At T = 1, 3, 5, 7, and 10 min 100 µl samples were 
taken . Each 100 µl samp le was pipetted into 900 µ1 of ice cold GBSS to stop uptake and 
dilute radionuclide. 
The samples were held on ice and centrifuged at the end of the time course for 5 
min at 1000 x g at 4 °C. Supematants were decanted and whi le still in the inve1ied 
position, the insides of the tube s were swab bed. The pellets were resuspend ed in 500 µI 
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of double-distilled water, and 100 µl aliquots taken for liquid scintillation 
spectrophotometry and 20 µl for protein determination. For each sample in the treated 
phase, cpm/µg of protein was normalized to the average basal cpm/µg of protein. Protein 
was assessed in duplicate using the Bradford reagent (BioRad, Hercules, CA) against 
bovine y-globulin as standard. 
32 P Uptake and Exogenous Catalase 
In another series of experiments, cell suspension plus radionuclide was pipetted 
into four fresh tubes, two of which contained bovine catalase (Sigma Chemical Co., St. 
Louis, MO) with subsequent addition of vehicle or steroids. The treatment conditions 
were (1) vehicle controls plus catalase; a.(2) 300 pM 1,25(0 H)2D3 plus 6.5 nM 
24,25(0H) 2D3 plus 50 nM catalase; orb (3) 300 pM 1,25(0H) 2D3 plus 6.5 nM 
24,25(0H) 2D3 plus 1 µM catalase; ( 4) 300 pM 1,25(0H)2 D3 plus 6.5 nM 24,25(0H)2D3. 
32 P Uptake and Catalase Inhibitor 
Cell suspensions were combined with H/ 2P0 4 as described above and aliquots 
pipetted into fresh tubes, two of which contained 1 µM 3-amino-1.2.4-triazole (Sigma). 
At T= 0, suspensions were treated with vehicle or steroid. The treatment groups were (1) 
controls plus catalase inhibitor; (2) 300 pM 1,25(0 H)3D3; and (3) 300 pM 1,25(0H) 3D3 
plus catalase inhibitor. 
32 P Uptake and 4/J-Phorbol 
12-myristate 13-acetate 
Cell suspensions were combined with H/ 2P0 4 as described above and aliquots 
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pipetted into fresh tubes, two of two of which contained 50 µM H20 2. At T= 0 min, cells 
were exposed to either the vehicle ethanol or 100 nM 4P-Phorbol 12-myristate 13-acetate 
(PMA; Sigma). The treatment conditions were (1) vehicle controls plus hydrogen 
peroxide; (2) hydrogen peroxide plus PMA; (3) PMA. 
Calculations 
For each time course, basal counts per minute per µg of protein were averaged, 
and used to normalize specific 32P uptake during the corresponding treated phase . 
Determination of PKC Activity 
Enzyme activity was determined in cell suspensions treated with vehicle, 300 pM 
1,25(0H) 2D3, 100 nM phorbol myristate acetate (PMA; Sigma), or PMA in cells 
pretreated with 50 µM H20 2. Cell suspensions were sampled at T=O, 1, 3, and 5 min . 
PKC activity was analyzed using a commercially availab le assay system (Upstate, Lake 
Placid , NY). After incubation, as described above, the cells were centrifuged at 1000 x g 
at 4°C for 10 min, the supernatant was decanted, and the pellet was stored at -20° C until 
analysis could be performed. Samples were placed on ice, 500 µI of chilled double-
distilled water was added, and the samp les homogenized. Ten µl of each sample 
( containing 10- 200 µg protein) were transfened into microfuge tubes on ice. Enzyme 
activity was assayed using [ y 32-P] ATP , and the substrate peptide [QKRPSQRSKYL]. 
Aliquot s of the incubation mixtures were spotted onto phosphocellulose disks ; the disks 
were washed and placed in scintillation vials for assessment of incorporated 
radioactivity. Protein concentrations were determined using the Bradford reagent as 
discussed above. 
Statistical Analyses 
Statistical comparisons between treatment groups were made by Sigma plot 9.0. 
using a two way ANOV A. Statistical significance was set at P<0.05. Results are 
expressed as Mean± SEM for 3-8 independent experiments. See appendix B for a 




32 P Uptake and Ab 365 to the 24,25(0H)2D3 
Binding Protein 
15 
Figure 2 shows the results of experiments designed to test whether neutralization 
of the 24,25(0H)2D 3 binding protein affects inhibition of the l ,25(0H)2D 3 response by 
the 24-hydroxylated steroid. Vehicle controls (final concentration 0.05% ethanol) 
incubated in the presence of Ab 365 showed a general decrease in 32P levels with time 
(open circles), as previously reported [Zhao and Nemere, 2002]. Addition of 
I ,25(0H)2D 3 to cell suspensions incubated in parallel resulted in enhanced levels of 
32P 
uptake that were evident within 1 min of hormone addition, and whjch became 
statisticall y signjficant at 3 tolO min (P<0.001 ), relative to corresponding controls. At 10 
min of incubation , I ,25(0H) 2D3-treated cells accumulated radionuclide to 132 % of 
controls. Incubation of cells in the presence of both l ,25(0H) 2D3 and 24,25(0H)2D3 
resulted in 32P uptake levels that were not significantly different than controls (Fig. 2), 
also as previously reported [Zhao and Nemere , 2002]. However , incubation of cells in the 
presence of Ab 365 and both steroids reversed the inhibition (Fig. 2). Radionuclide 
levels were noticeable greater in such cell suspe nsions within 1 min , and became 
sign ificantl y greater than corresponding incubations without antibody at 3 to 10 min 
(P<0.001) (Fig. 3). After 10 min of incubation , cells treated with both stero ids in the 
presence of Ab 365 exh ibited 32P uptake that was 150 % of cells incubated with both 
steroids and no antibody. 
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Fig. 2. Time course of 32P Uptake and effect of Ab 365 against the 24,25(0H) 20 3 binding 
protein . Enterocytes isolated by citrate chelation were resuspended in Gey's Balanced 
Salt Solution (GBSS; 23° C), and combined with 2 µCi /ml of H/ 2P0 4, at which point the 
time course was initiated. Aliquots of cell suspension were pipetted into four fresh tubes, 
three of which contained Ab 365 at a 11100 final dilution. Samples were removed at T=-
5 and -1 min to establish basal uptake . At T =O min, the cells were treated with vehicle or 
steroids to produce the following incubation conditions: (I) controls plus Ab 365 ( o- o; 
n=7) ; (2) 300 pM 1,25(0H) 20 3 plus Ab 365 (•-•; n=7); (3) 300 pM l ,25(0H) 20 3 plus 
6.5 nM 24,25(0H)z0 3 (fl -fl; n=7); (4) 300 pM 1,25(0H) 2D3 plus 6.5 nM 24,25(0H) 20 3 
plus antibody Ab 365 ( A - A ; n=7). At T = 1, 3, 5, 7, and 10 min 100 µl samples were 
taken and pipetted into 900 µl of ice-cold GBSS. Cell samples were centrifuged (1000 x 
g, 5 min), supematants decanted, and pellets analyzed for radioactivity activity and 
protein. Radionuclide was related to corresponding cellular protein in each aliquot , and 
then nonnalized to average basal cpm/µg protein . Data are presented as mean 
treated /average basal ratios± SEM . 
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32 P uptake and Effect of Exogenous Catalase 
Figure 3 illustrates the results of experiments designed to test whether addition of 
exogenous catalase overcomes the inhibitory effect of 24,25(0H)2D 3. Vehicle controls 
showed a general decrease in 32P levels with time (open circles), as noted above. 
uptake levels that were not significantly different than controls (Fig. 3), also as 
previously reported [Zhao and Nemere, 2002]. Exogenous catalase reversed the 
24,25(0H)2D3-mediated inhibition of 1,25(0H)2 D3. Addition of l ,25(0H) 2D3 and 
24,25(0H) 2D3 and either 0.05 or 1.0 µM bovine catalase to cell suspension incubated in 
parallel resulted in enhanced levels of 32P uptake that were evident within 1 min of 
hormone addition, and which became statistically significant at 5 to 10 min (P = 0.02-
0.001 ), relative to corresponding controls or corresponding samples from cells treated 
with both steroids alone. At 10 min of incubation, cells treated with both steroids plus 
0.05 µM catalase accumulated radionuclide to 140 % of vehicle controls , while tho se 
exposed to 1 µM catalase exhibited 32P levels that were 135% of vehicle controls. 
32 P uptake and Effect of Catalase Inhibitor 
Figure 4 depicts the results of experiments designed to test whether addition of 
catalase inhibitor duplicates the inhibitory effect of 24,25(0H) 2D3. Vehicle controls 
showed a general decrease in 32P levels with time (open circles), as noted above. 
Incubation of cells in the presence of both l ,25(0H)2D 3 and catalase inhibitor , as well as 
l ,25(0H) 20 3 and 24,25(0H) 2D3 resulted in 
32P uptake levels that were not significantly 
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Fig . 3. Time course study of 32P uptake and effect of exogenous catalase in isolated 
intestinal cells . Enterocytes were isolated and exposed to radionuclide as described in the 
legend to Fig. 2. Aliquots of cell suspensions were pipetted into four fresh tubes, two of 
which contained 0.05 or 1.0 µM bovine catalase . Samples were removed at T= -5 and -1 
min to establish basal uptake. At T = 0 min, the cells were treated with vehicle or steroids 
to produce the following incubation conditions: (1) controls plus catalase ( o- o ; n=5); (2) 
300 pM l,25(0H)zD 3 plus 6.5 nM 24,25(0H)zD 3 plus 0.05 µM catalase ( •-• ; n=5); (3) 
300 pM l ,25(0H)zD 3 plus 6.5 nM 24,25(0H)zD 3 plus 1.0 µM catalase (A-A ; n=5); (4) 
300 pM l ,25(0H) 2D3 plus 6.5 nM 24,25(0H)zD 3 (6-6; n=5). At T = 1, 3, 5, 7, and 10 
min 100 µI samples were taken and pipetted into 900 µl of ice-cold GBSS. Cell samples 
were centrifuged (1000 x g, 5 min), supernatants decanted, and pellets analyzed for 
radioactivity activity and protein. Radionuclide was related to corresponding cellular 
protein in each aliquot , and then nonnalized to average basal cpm /µg protein. Data are 
presented as mean treated /average basal ratios± SEM. 
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Fig . 4. Tim e course study of 32P uptake and effect of catalase inhibitor in isolated 
intestinal cells. Enterocyt es were isolated and exposed to radionuclide as described in the 
legend to Fig . 2 . Aliquots of cell suspension were pipetted into four fresh tubes , two of 
which contained 1 µM catalase inhibitor (3-amino-1,2,4-triazole) . Samples were 
removed at T= -5 and -1 min to establish basal uptake . At T = 0 min, the cells were 
treated with vehicle or steroids to produce the following incubation conditions : (1) 
controls plus catalase inhibitor ( o- o ; n=5); (2) 300 pM 1,25(0H)2D 3 plus catalase 
inhibitor(•-• ; n=5); (3) 300 pM 1,25(0H) 2D3 (A-A ; n=5); (4) 300 pM 1,25(0H) 2D3 
plus 6.5 nM 24,25(0H) 2D3 (.6- .6; n=5). At T = 1, 3, 5, 7, and 10 min 100 µl samples 
were taken and pipetted into 900 µl of ice-cold GBSS. Cell samples were centrifuged 
(1000 x g, 5 min) , supematants decanted, and pellets analyzed for radioactivity activity 
and protein . Radionuclide was related to corresponding cellular protein in each aliquot , 
and then normalized to average basal cpm/µg protein . Data are presented as mean 
treated /average basal ratios ± SEM. 
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inhibition of 1,25(0H) 2 D3. Addition of l ,25(0H)2D 3 alone, resulted in enhanced levels 
of 32P uptake that were evident within 1 min of honnone addition, and which became 
statistically significant at 3 to 10 min (P = 0.01-0.001), relative to corresponding controls 
or corresponding samples from cells treated with both steroids alone. At 10 min of 
incubation, cells treated with l ,25(0H) 2D3 accumulated radionuclide to 133 % of vehicle 
controls, while those exposed to catalase inhibitor or honnone alone exhibited 32P levels 
that were less than± 2% of vehicle controls. 
32 P Uptake and 4/J-Phorbol 12-myristate 
13-acetate 
Figure 5 illustrates the resuits of experiments designed to test whether the 
production of hydrogen peroxide mediated by 24,25(0H)2D 3 can act to inhibit PKC 
signaling independently of its action on the 1,25D 3-MARRS receptor. In these studies 
addition of 4~-Phorbol 12-myristate 13-acetate (PMA) was used to activate PKC. Vehicle 
controls plus H20 2 showed a general decrease in 
32P levels with time (open circles) , but 
the decline was equivalent to that seen in the absence of oxidant. Incubation of cells in 
the presence of both hydrogen peroxide and PMA , resulted in 32P uptake levels that were 
not significantly different than controls (Fig. 5). Addition of PMA alone, resulted in 
enhanced levels of 32 P uptake that were evident within I min after addition , and which 
became statistically significant at 5 to IO min (P = 0.02-0.001 ), relative to corresponding 
controls or corresponding samples from cells treated with both hydrogen peroxide and 
PMA. At 10 min of incubation , cells treated with PMA accumulated radionuclide to 143 
% of vehicle controls , while those exposed to hydrogen peroxide and PMA exhibited 
32
P 
levels that were less than ± 2% of vehicle controls. 
Effect of PMA in the Absence and Presence 
ofH 202 on PKC Activity 
Earlier evidence [Nemere et al. , 2006 manuscript submitted] indicated that 
inactivation of the l ,25D 3-MARRS receptor by either 24,25(0H)2D 3 or 50 µM H20 2 
required 5-20 min of incubation, while inhibition of either phosphate uptake or 
l ,25(0H)2D 3-stimulated PKC activity occun-ed within 1 min. And as shown in Fig. 5, 
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direct stimulation of phosphate uptake with phorbol ester was rapidly inhibited by H20 2, 
suggesting that the oxidant might directly inhibit PKC activation. Experiments were 
therefore performed to assess this possibility. 
Figure 6 illustrates the time course of PKC activation in response to treatment of 
isolated intestinal epithelial cells with I 00 nM PMA in the absence or presence of 50 µM 
H20 2. Vehicle controls incubated in the presence of hydrogen peroxide showed a 
decrease in PKC level s with time (open circles) . Stimulation of PKC activity was 
detected 1 minute after addition of PMA. Protein kinase C levels were noticeably greater 
in such cell suspension within 1 min, and became significantly greater than 
corresponding incubations with H20 2 at 3 to 5 min (P<0.05; Fig. 6). At 5 min of 
incubation , PMA-treated cells showed PKC levels 148 % of controls. 
PKC activity was stimulated to a lesser degree by the addition of 1,25(0H) 2D3. 
Incubation of cells in the presence of both PMA and H20 2 resulted in PKC levels that 
were not significantly different than controls (Fig. 6). 
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Fig. 5. Time course study of 32P uptake and effect of 4r-Phorbol 12-myristate 13-acetate 
(PMA) in isolated intestinal cells. Enterocytes were isolated and exposed to radionuclide 
as described in the legend to Fig . 2. Aliquots of cell suspension were pipetted into three 
fresh tubes , two of which contained 50 µM H20 2. Samples were removed at T= -5 and -1 
min to establish basal uptake. At T = 0 min , the cells were treated with 100 nM PMA or 
vehicle to produce the following incubation conditions : (1) controls plus 50 µM H20 2 , 
(o- o ; n=3) ; (2) 100 nM PMA plus 50 µM H20 2 (•-•; n=3); (3) 100 nM PMA (.A-.A ; 
n=3) At T = 1, 3, 5, 7, and 10 min 100 µl samples were taken and pipetted into 900 µl of 
ice-cold GBSS. Cell samples were centrifuged (1000 x g, 5 min), supematants decanted , 
and pellets analy zed for radioactivity activity and protein . Radionuclide was related to 
conesponding cellular protein in each aliquot , and then normali zed to average basal 
cpm/µg protein. Data are presented as mean treated/average basal ratio s± SEM . 
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Fig. 6. Time course study of PKC activation by 4r-Phorbol 12-myristate 13-acetate 
(PMA) in isolated intestinal cells. At T = 0 min , the cells were treated with H20 2, PMA , 
or 1,25(0H) 2D3 to produce the following incubation conditions: (1) Contro l plus 50 µM 
H20 2 (o- o ; n=3 ); (2) 50 ~lM H20 2 plus 100 nM PMA (•-•; n=3); (3) lOOnM PMA 
( •- • ; n=3); ( 4) 300 pM 1,25(0H)2D 3 (Li-Li; n=2). Cell suspensions were sampled at 
T=O, 1, 3, and 5 min. After incubation , as described above, the cells were centrifuged at 
1000 x g at 4°C for 10 min, the supernatant was decanted , and the pellet was stored at -
20 ° C until analysis could be performed. Samples were placed on ice , 500 µI of chilled 
doub le-distilled water was added, and the samples homogeni zed. Samples were 
transfen-ed into microfuge tubes on ice . PKC activity was analyzed using [y 32-P] ATP, 
and the substrate peptide [QKRPSQRSKYL]. Aliquots of the incubation mixtures were 
spotted onto phosphocellulose disks , washed and placed into scintillation via ls for 
determination of radioactivity activity. 
CHAPTER IV 
DISCUSSION 
The current work considerablely increases our understanding of the vitamin D 
endocrine system through further explanation of the signal transduction pathway that 
allows 24,25(0H) 20 3 to inhibit the actions of l ,25(0H) 203. 
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In a previous report , a cellular binding protein for 24,25(0H) 20 3 was established 
to be the enzyme catalase [Larsson et al., 2006]. Treatment of intestinal cells with 
24,25(0H) 20 3 was subsequently found to inhibit catalase activity and promote an 
increase in H20 2 formation [Nemere et al., 2006 manuscript submitted] . It was 
hypothesized that the H20 2 might , in tum, oxidize thiols within the 1,25D3-MARRS 
receptor to decrease binding of 1,25(0H) 2D3, and ultimately inhibit stimulated phosphate 
uptake . 
ln the present work , it was found that neutralization of the 24,25(0H)z0 3 binding 
protein with Ab 365 in cells treated with both 24,25(0H)z03 and 1,25(0H)zD3 
effectively reversed the inhibition. These results extend another work [Larsson et al., 
2006] in which commercially available anti-catalase antibody was also found to reverse 
24,25(0H) 2D3 inhibition of 1,25(0H) 2D3-stimulated phosphate uptake in isolated 
intestinal epithelial cells. Moreover , Ab 365 directed against a protein isolated on the 
basi s of specific [3H]24,25(0H)zD 3 binding , was demonstrated to recognize bovine 
catalase by Western analysis [Larsson et al., 2006]. 
In the current study, the addition of exogenous catalase also reversed the 
24 ,25(0H) 2D3-mediated inhibition of l ,25(0I-1)2 0 3. Although whether this occurred 
through the enzyme's catalytic activity or through sequestration of 24,25(0H) 20 3 was 
not determined. 
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In addition, catalase inhibitor reproduced the 24,25(0H) 20 3-mediated inhibition 
of 1,25(0H) 2 0 3. This suggests that catalase has a central role in mediating rapid 
responses to steroid honnones. 
In other work [Nemere et al., 2006 manuscript submitted], incubation of isolated 
intestinal epithelial cells with 24,25(0H) 20 3 resulted in a time-dependent decrease in the 
ability of the 1,250 3-MARRS receptor to bind its ligand. Decreased binding was not 
evident after 5 min of incubation, indicating two things: 24,25(08) 20 3 does not compete 
with l ,25(0H) 2D3 for binding to the 1,250 3-MARRS receptor, as previously reported 
fNemere et al., 1994]; and there must be an additional, more rapid mechanism to account 
for the inhibitory effects of 24,25(0H) 2D 3. Thus, experiments were performed to assess 
the prospect of hydrogen peroxides ability to down regulate PKC activity. Phorbol ester 
was first demonstrated to stimulate phosphate uptake in isolated enterocytes, and 
enhanced uptake was found to be susceptible to inhibition by H20 2, strongly suggesting 
that PKC, the signal transduction pathway responsible for mediating phosphate uptake, 
was a target of oxidant activity. Finally , by measuring PKC activity in response to 
phorbol, it was found that H20 2 did directly abolish stimulation. 
The combined research has implications at the organismal level. In agriculture, a 
serious problem with poultry fanning is the production of manure high in phosphates. 
While beneficial for crop production , leaching of the phosphates into nearby waterways 
has had a damaging effect on ecology. ft is likel y that by increasing dietar y antioxidants, 
phosphate absorption will be increased, with concomitant decreases in manure levels. 
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Beyond agriculture , these studies have implications for bone health in all 
animals , including humans. Diets enriched in antioxida nts have been found to promote 
bone health [Lean et al., 2003]. In relation to this, Magne et al. [2003] have reported that 
the cellular signal for bone mineralization is increased phosphate : While phosphate is not 
a limiting nutrient , as calcium is , it is apparently subject to intricate regulation . Earlier 
work in this lab has demonstrated that the rapid stimula tion of phosphate absorption 
through the l ,25D 3-MARRS receptor is confined to growing animals [Nemere et al., 
2004], which correlates with periods of rapid bone formation. It is moreover believed 
that by maximizing bone mineral density early in life , osteoporosis can be ameliorated. 
Clearly, a viable strategy for enhancing bone fonnation may be diets rich in antioxidants . 
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Appendix A . Abbreviations 
µCi .......................... ... Microcurie , a term used to quantify radioactivity. 
µg .... ............... .. ......... . Micrograms. 
µI ........ ........................ Microliter. 
1,25(0HhD 3 ........ ....... 1,25-dihydroxyvitamin D3. 
1,25D 3-MARRS ......... 1,25-dihydrox yvitamin D3 membrane-associated , rapid -response 
steroid-binding) protein. 
24,25(0H) 2D3 ............. 24,25-dihydroxyvitamin D3. 
25(0H)D 3 ...... ........... ... 25 -hydro xyvita min 03. 
32p Rad;o;S"''"'~ a ,-.,+ ~h ,-.,~~hA~A"S +rA•~ nhh rA";a•crl -A·a·1· "'- A+ 
.1 .. . ............ .. ............... .1 . .l .l VL.VJJI,,.., Vl JJllV.:'>t-JllVlVLl llVJlJ UUVl\..., Y l L \J JJVl. l Vll Vl 
3? H3 -po 4. 
45 Ca .... ......... ..... ... ....... Radioi sotop e of calcium. 
Ab 365 ............. .. ........ . Antibod y 365, used to block the 24,25(0H) 20 3 binding protein. 
ANOVA ................ .... . Analysis of Variant s. 
BP .......... ............. ........ Binding prot ein . 
C ..... ... ........... ....... ....... Celsius. 
Ca2+ ........ ... ... .............. Calcium . 
CaBP .... ......... ............. Calcium bindin g protein , also tenn ed Ca lbindin 28k· 
cpm /µg ............. ... ....... Counts Per Minute ove r Microgram s of protein . 
ELISA ........................ Enzyme-Linked lmmuno sorbent Assay . 
g ............... ................... Gravity . 
36 
37 
GBSS .. ........ ................ Gey's Balanced Salt Solution . 
H20 2 ................... ... ..... Hydrogen peroxide. 
mM ............................. Millimolar. 
mRNA ...... ...... ........... . Messenger RNA. 
nM ........... .......... ........ . Nanomolar. 
P ............ .... ........... ... ... P-value statistical measure. 
PK.A .... ..... ........... ........ Protein Kinase A. 
PKC ... .......... ..... .......... Protein Kinase C. 
pM .............................. Picomolar . 
PMA ....... ................... .4~-Phorbol 12-myri state 13-acetate. 
SEM ..... .... ...... ..... ....... Standard Error of the Mean. 
T ..... ....... .... .... ............. Abbreviation of Time. 
VDR .......... ........ .... ..... Vitamin D Nuclear Receptor. 
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Appendix B. Statistical Ana lyses 
Table A. AN OVA for figure 2. Time course of 32P Uptake and effect of Ab 365 
against the24,25(0H) 2D3 binding protein. 
Source of Variation DF SS MS F p 
Treatment 3 1.070 0.357 26.264 <0.001 
Time 6 0.700 0.117 8.596 <0.001 
Treatment x Time 18 0.605 0.0336 2.476 0.002 
Residual 140 1.901 0.0136 
Total 167 4.369 0.0262 
39 
Table B. AN OVA for figure 3. Time course study of 32P uptake and effect of exogenous 
catalase in isolated intestinal cells. 
Source of Variation DF SS MS F p 
Trt 3 0.528 0.176 11.562 <0.001 
Time 6 0.501 0.0835 5.485 <0.001 
Trt x Time 18 0.449 0.0249 1.637 0.062 
Residual 112 1.705 0.0152 
Total 139 3.182 0.0229 
Table C. ANOV A for figure 4. Time course study of 32P uptake and effect of ca ta lase 
inhibitor in isolated intestinal cells . 
Source of Variation DF SS MS F p 
Trt 3 0.598 0.199 15.732 <0.001 
Time 6 0.572 0.0953 7.521 <0.001 
T1i x Time 18 0.407 0.0226 1.786 0.035 
Residual 112 1.419 0.0127 
Total 139 2.996 0.0216 
Table D . ANOV A for figure 5. Time course study of 32P uptake and effect of 4f3-Phorbol 
12-myristate 13-acetate (PMA) in isolated intestinal cells. 
Source of Variation DF SS MS F p 
conditions 2 0.298 0.149 10.865 <0.001 
TIME 6 0.389 0.0648 4.721 <0.001 
conditions x TIME 12 0.368 0.0307 2.234 0.027 
Residual 42 0.577 0.0137 
Total 62 1.633 0.0263 
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Table E. ANO VA for figure 6. Time course study of PKC activation by 4~-Phorbol 
12-myristate 13-acetate (PMA) in isolated intestinal cells. 
·-
Source of Variation DF SS MS F p 
conditions 3 0.389 0.130 14.325 <0.001 
TIME 3 0.0633 0.0211 2.330 0.013 
conditions x TIME 9 0.161 0.0178 1.970 0.013 
Residual 16 0.145 0.00905 
Total 31 0.758 0.0244 

